PCN39 EXPLORATORY COST EFFECTIVENESS ANALYSIS OF BEVACIZUMAB IN ADDITION TO FOLFOX-4 IN THE ADJUVANT TREATMENT OF STAGE III COLON CANCER- A UK PERSPECTIVE
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66575-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)66575-8/fulltext
Title :
PCN39 EXPLORATORY COST EFFECTIVENESS ANALYSIS OF BEVACIZUMAB IN ADDITION TO FOLFOX-4 IN THE ADJUVANT TREATMENT OF STAGE III COLON CANCER- A UK PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66575-8&doi=10.1016/S1098-3015(10)66575-8
First page :
Section Title :
Open access? :
No
Section Order :
409